Lyophilization Technology for

COVID-19 Vaccines

Freeze-Drying of Liquid Vaccines to Produce Stable, Rapidly Dissolving Powders


About our Technology

We are adapting our patented continuous lyophilization (freeze-drying) technology to the production of vaccines. 

Originally developed for the production of sterile injectables, we have changed our focus and are now pursuing the production of sterile, room temperature stable powder vaccines. 

We are actively searching for partners who are experts and pioneers in the research and development of novel vaccines so that we can take on the challenge of producing powdered vaccines made via the latest technology.


Progress through Innovation


Factory Construction

Layout and Schedule
(Startup planned for Mid 2022)

Research Collaboration

Learn about how we can work together


Contract Manufacturing

Freeze-dry your vaccines with our facilities & equipment